Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2007-001602-24Phase 3Completed
Phase 3, randomised trial of botulinum toxin type A in Prostatodynia (CP/CPPS) (2 arms), sponsored by Justus Liebig University Giessen. Primary endpoint: Primary: Reduction in NIH-CPSI score at 3 months. Started Jun 2009; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2007-001602-24.